Open AccessTocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia
Author(s) -
RavindraM Mehta,
Sameer Bansal,
Uma Karjigi
Publication year - 2021
Publication title -
apollo medicine
Language(s) - English
Resource type - Journals
eISSN - 2213-3682
pISSN - 0976-0016
DOI - 10.4103/am.am_88_21
Subject(s) - tocilizumab , medicine , pneumonia , cytokine release syndrome , cytokine storm , confidence interval , hazard ratio , covid-19 , rheumatoid arthritis , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom